Telehealth has helped patients living with chronic conditions, such as type 1 diabetes, continue their care management throughout the pandemic, new research shows.
According to the global survey of patients living with type 1 diabetes, many moved to telehealth because in-person doctor visits were curtailed as a result of COVID lockdown restrictions. But even after the pandemic has passed, three-quarters say they will continue to take advantage of telehealth solutions to meet their care management needs.
The information, presented this week at the Annual Meeting of the European Association for the Study of Diabetes (EASD), highlights the value of telehealth platforms in maintaining care management during times of unprecedented disruption to daily life.
Furthermore, many patients with chronic conditions will have foregone check-ups throughout the pandemic for fear of becoming infected or adding an extra burden to healthcare providers. Telehealth has a significant role to play hear by helping these individuals re-establish their care routines and get the treatment they require.
The study conducted by researchers at the University of Bern in Switzerland and supported by Novo Nordisk, involving more than 7,000 people in 89 countries, is published in in the journal Endocrinology, Diabetes & Metabolism.
“The results … demonstrate that a large number of people living with type 1 diabetes have rapidly adopted telemedicine or plan to in the near future and that this has generally been perceived positively,” the researchers concluded in the study.